🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi’an
Clinical trial register · China

Clinical Trials in Xi’an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Xi'an 7 Ankang 3 Hanzhong 2 Xianyang 1 Pingdingshan 1
Narrow the registerReset
Recruitment status
Phase
Site location
Xi'an7 Ankang3 Hanzhong2 Xianyang1 Pingdingshan1
All 10 locations
Target enrolment
to

Trials with a site in Xi’an

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis
NCT07542652Gastric Carcinoma, Gastritis Chronic, Intestinal Metaplasia, Gastric Precancerous Lesions
Yongquan Shi
Observational
450
Xi'an
2026-03-31
Recruiting
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis(UPFRONT)
NCT07546097Acute Severe Ulcerative Colitis
Yongquan Shi
Phase 4
46
Ankang, Hanzhong, Xi'an, Xianyang
2026-03-23
Recruiting
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
NCT07139366Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer
Yongquan Shi
Phase 4
1,248
Xi'an
2025-10-28
Recruiting
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
NCT07068607Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
Yongquan Shi
Phase 4
400
Xi'an
2025-04-01
Recruiting
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
NCT06610266Gastric Intestinal Metaplasia
Yongquan Shi
Phase 4
400
Ankang, Tongchuan, Weinan, Xi'an, Xuchang, Yanan
2025-02-28
Recruiting
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
NCT06610760Gastric Intestinal Metaplasia
Yongquan Shi
Phase 4
196
Pingdingshan, Ankang, Hanzhong, Shangluo, Xi'an
2024-11-12
Recruiting
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
NCT06617182Radiation Enteritis
Yongquan Shi
Phase 2
150
Xi'an
2024-09-30
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Xi’an that also match the filters currently applied.

How many clinical trials are recruiting in Xi’an?

7 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xi’an), 7 studies
PhaseStudiesRecruitingShare
Phase 45571.4%
Observational1114.3%
Phase 21114.3%

Most active sponsors

Lead sponsors with the most studies (Xi’an)
Lead sponsorStudiesRecruiting
Yongquan Shi77
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.